REVIEW

The role of the tumour suppressor p33^ING1b in human neoplasia

G S Nouman¹, J J Anderson¹, J Lunec² and B Angus¹

¹ Pathology Department, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4PH, UK
² Cancer Research Unit, University of Newcastle, Queens Victoria Road, Newcastle upon Tyne NE1 4PH, UK

Correspondence to:
Correspondence to:
Dr G S Nouman, Pathology Department, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4PH, UK;
ghassan9{at}aol.com

The inhibitor of growth (ING) genes (ING1–4) probably descend from tumour suppressor genes. ING1 was the first to be identified and later isolated using an approach to detect genes whose expression is suppressed in cancer. The others were isolated through homology and similarity searches in human and mouse databases. All members contain a plant homeodomain involved in macromolecule recognition. Apart from the extensively studied ING1, little is known about the number of transcripts encoded by the other members or their gene structure. ING1 encodes several differentially spliced mRNAs, which may produce a family of proteins. The most widely expressed protein isoform is p33^INGb1, which is involved in restriction of cell growth and proliferation, apoptosis, tumour anchorage independent growth, cellular senescence, maintenance of genomic stability, and modulation of cell cycle checkpoints. ING1 gene mutation is uncommon in cancer, although the subcellular localisation of p33^INGb1 may have an effect on its function. The p33^INGb1 cellular compartmental shift from the nucleus to the cytoplasm may cause loss of normal cellular function, and may play a central role in the pathogenesis of several cancers.

Keywords: ING1; ING2; p33^ING1b; p53; tumour suppressors

Abbreviations: aa, amino acids; GSE, genetic suppressor element; HDAC1, histone deacetylation complex 1; ING, inhibitor of growth; LOH, loss of heterozygosity; NLS, nuclear localisation signal; NTS, nucleolar targeting sequence; PCNA, proliferating cell nuclear targeting antigen; PHD, plant homeodomain; PIP, proliferating cell nuclear targeting antigen interacting protein domain; pRb, retinoblastoma protein; SAID, SAP30 interacting domain; UV, ultraviolet

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Coles, A. H., Marfella, C. G.A., Imbalzano, A. N., Steinman, H. A., Garlick, D. S., Gerstein, R. M., Jones, S. N. (2008). p37Ing1b Regulates B-Cell Proliferation and Cooperates with p53 to Suppress Diffuse Large B-Cell Lymphomagenesis. Cancer Res. 68: 8705-8714 [Abstract] [Full Text]  
• Abad, M., Menendez, C., Fuchtbauer, A., Serrano, M., Fuchtbauer, E.-M., Palmero, I. (2007). Ing1 Mediates p53 Accumulation and Chromatin Modification in Response to Oncogenic Stress. J. Biol. Chem. 282: 31060-31067 [Abstract] [Full Text]  
• Coles, A. H., Liang, H., Zhu, Z., Marfella, C. G.A., Kang, J., Imbalzano, A. N., Jones, S. N. (2007). Deletion of p37Ing1 in Mice Reveals a p53-Independent Role for Ing1 in the Suppression of Cell Proliferation, Apoptosis, and Tumorigenesis. Cancer Res. 67: 2054-2061 [Abstract] [Full Text]  
• Pedeux, R., Sengupta, S., Shen, J. C., Demidov, O. N., Saito, S., Onogi, H., Kumamoto, K., Wincovitch, S., Garfield, S. H., McMenamin, M., Nagashima, M., Grossman, S. R., Appella, E., Harris, C. C. (2005). ING2 Regulates the Onset of Replicative Senescence by Induction of p300-Dependent p53 Acetylation. Mol. Cell. Biol. 25: 6639-6648 [Abstract] [Full Text]  
• Goeman, F., Thormeyer, D., Abad, M., Serrano, M., Schmidt, O., Palmero, I., Baniahmad, A. (2005). Growth Inhibition by the Tumor Suppressor p33ING1 in Immortalized and Primary Cells: Involvement of Two Silencing Domains and Effect of Ras. Mol. Cell. Biol. 25: 422-431 [Abstract] [Full Text]